Référentiel des médicaments
Sucroferric oxyhydroxide
Sucroferric oxyhydroxide is a medicine in the class genitourinary. It is used for serum phosphorus regulation.
- Classe médicamenteuse: Genitourinary
- Indications: serum phosphorus regulation
Dernière mise à jour Sources: US FDA label
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
L'essentiel
- Classe médicamenteuse
- Genitourinary
- Code ATC
- V03AE05
- Dosages courants
- 500 mg
- Interactions connues
- 5 (Modérée: 3 · Mineure: 2)
- Noms commerciaux
- 2
- Pays et marchés
- 2
Indications
Mécanisme d'action
Phosphate binding occurs in the GI tract by ligand exchange between hydroxyl groups and/or water in sucroferric oxyhydroxide and dietary phosphate. Bound phosphate is eliminated in feces, reducing serum phosphorus and calcium-phosphorus product.
Posologie adulte habituelle (résumé de la notice)
Control of serum phosphorus in CKD on dialysis: starting dose one 500 mg tablet three times daily with meals, oral; adjust by one 500 mg tablet per day as needed, titrating as often as weekly; doses up to 3,000 mg per day have been studied
Grossesse et allaitement
- Grossesse
- Unknown Not systemically absorbed; maternal use is not expected to result in fetal exposure. Animal studies showed some effects at high doses in rabbits and rats.
- Allaitement
- Unknown Not systemically absorbed; breastfeeding is not expected to result in infant exposure.
Effets indésirables signalés
- Diarrhea
- Discolored feces
- Nausea
- Product taste abnormal
- Tooth discoloration
- Rash
Précautions particulières
- Patients with peritonitis during peritoneal dialysis, significant gastric or hepatic disorders, recent major GI surgery, hemochromatosis or other iron accumulation diseases were not studied; monitor effect and iron homeostasis.
Informez votre pharmacien ou votre médecin en cas de grossesse ou d'allaitement, de maladie rénale ou hépatique, d'allergies, ainsi que de tout autre médicament ou complément que vous prenez.
Principales interactions (5)
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour ouvrir la monographie complète de Sucroferric oxyhydroxide : posologie, grossesse et allaitement, effets indésirables, mises en garde et toutes les interactions.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
Essayez Pro+ gratuitement pendant 7 jours sur le web. Sans carte.
Questions fréquentes
What is Sucroferric oxyhydroxide used for?
Sucroferric oxyhydroxide is a medicine in the class genitourinary. It is used for Serum phosphorus regulation.
What side effects have been reported with Sucroferric oxyhydroxide?
Diarrhea, Discolored feces, Nausea, Product taste abnormal, Tooth discoloration, Rash.
Can Sucroferric oxyhydroxide be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Not systemically absorbed; maternal use is not expected to result in fetal exposure. Animal studies showed some effects at high doses in rabbits and rats. Breastfeeding: Unknown. Not systemically absorbed; breastfeeding is not expected to result in infant exposure.
What does Sucroferric oxyhydroxide interact with?
MediHelp lists 5 known interactions for Sucroferric oxyhydroxide. Moderate: 3 · Minor: 2. The most serious include Alendronate, Doxycycline, Levothyroxine.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
